None
Quote | Savara Inc. (NASDAQ:SVRA)
Last: | $4.24 |
---|---|
Change Percent: | 0.64% |
Open: | $4.66 |
Close: | $4.24 |
High: | $4.72 |
Low: | $4.24 |
Volume: | 1,001,895 |
Last Trade Date Time: | 04/24/2024 03:00:00 am |
News | Savara Inc. (NASDAQ:SVRA)
2024-04-18 16:56:16 ET Gainers: Travere Therapeutics ( TVTX ) +6% . Sabre Corporation ( SABR ) +5% . Nextracker ( NXT ) +3% . Cipher Mining ( CIFR ) +3% . BioCryst Pharmaceuticals ( BCRX ) +3% . Losers: Avidit...
Savara’s Partner, Trillium Health LLC, to Present Data on the Laboratory Blood Test for Diagnosing aPAP Company to Host Industry Theater on Pulmonary Alveolar Proteinosis (PAP) with Two World-Renowned Experts Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage ...
Message Board Posts | Savara Inc. (NASDAQ:SVRA)
Subject | By | Source | When |
---|---|---|---|
Impala must be doing better ... hod $2.82 | AKAPAK | investorshub | 01/26/2023 5:46:22 PM |
Wake up call to the board $2.47 | AKAPAK | investorshub | 01/25/2023 6:35:04 PM |
Finally done dumping on the new financials. | Mrfairfield | investorshub | 05/14/2021 1:57:56 PM |
Looking for comments, | 20stockman20 | investorshub | 03/23/2021 2:32:06 PM |
Wow looks like dump is still on imo | Roadtojourney | investorshub | 03/22/2021 7:23:04 PM |
News, Short Squeeze, Breakout and More Instantly...
Savara’s Partner, Trillium Health LLC, to Present Data on the Laboratory Blood Test for Diagnosing aPAP Company to Host Industry Theater on Pulmonary Alveolar Proteinosis (PAP) with Two World-Renowned Experts Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage ...
Remains On-Track to Report Top Line Data from the Pivotal Phase 3 IMPALA-2 Trial by End of 2Q 2024 48-week placebo-controlled trial is evaluating molgramostim nebulizer solution (molgramostim), a novel inhaled biologic, for the treatment of autoimmune Pulmonary Alveolar Proteinosis (aPAP)...
Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will participate in a fireside chat at the Barclays 26th Annual Global Healthcare Conference on March 14, 2024 at 5:00am PT/8:00am ET. A live web...